159 related articles for article (PubMed ID: 33112006)
1. Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway.
Liu J; Zhang Y; Yu C; Zhang P; Gu S; Wang G; Xiao H; Li S
Drug Dev Res; 2021 Apr; 82(2):278-286. PubMed ID: 33112006
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway.
Su D; Lv C
Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713
[TBL] [Abstract][Full Text] [Related]
3. Di-(2-ethylhexyl)-phthalate induces apoptosis via the PPARγ/PTEN/AKT pathway in differentiated human embryonic stem cells.
Fang H; Fang W; Cao H; Luo S; Cong J; Liu S; Pan F; Jia X
Food Chem Toxicol; 2019 Sep; 131():110552. PubMed ID: 31163220
[TBL] [Abstract][Full Text] [Related]
4. Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of bladder cancer by activating PPARγ/PTEN/AKT pathway.
Zhang P; Sun Y; Shi L; Sun D; Wang L; Feng D; Ding C
Tissue Cell; 2023 Jun; 82():102048. PubMed ID: 36905861
[TBL] [Abstract][Full Text] [Related]
5. Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
Wang X; Lyu J; Ji A; Zhang Q; Liao G
Life Sci; 2019 Aug; 230():162-168. PubMed ID: 31125562
[TBL] [Abstract][Full Text] [Related]
6. Piceatannol inhibits proliferation and induces apoptosis of bladder cancer cells through regulation of the PTEN/AKT signal pathway.
Li XG; Zhang WS; Yan XP
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):181-184. PubMed ID: 32538768
[TBL] [Abstract][Full Text] [Related]
7. The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway.
Chen Z
Urol Int; 2023; 107(9):848-856. PubMed ID: 37666229
[TBL] [Abstract][Full Text] [Related]
8. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
Lv S; Wang W; Wang H; Zhu Y; Lei C
BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression.
Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
Anticancer Agents Med Chem; 2021; 21(1):108-119. PubMed ID: 32807067
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
Han S; Roman J
Mol Cancer Ther; 2006 Feb; 5(2):430-7. PubMed ID: 16505118
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.
Wang G; Cao R; Wang Y; Qian G; Dan HC; Jiang W; Ju L; Wu M; Xiao Y; Wang X
Sci Rep; 2016 Oct; 6():35783. PubMed ID: 27779188
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_0072309 inhibits the proliferation, invasion and migration of gastric cancer cells via inhibition of PI3K/AKT signaling by activating PPARγ/PTEN signaling.
Guo X; Qin M; Hong H; Xue X; Fang J; Jiang L; Kuang Y; Gao L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760104
[TBL] [Abstract][Full Text] [Related]
13. PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway.
Ni J; Zhou LL; Ding L; Zhao X; Cao H; Fan F; Li H; Lou R; Du Y; Dong S; Liu S; Wang Z; Ma R; Wu J; Feng J
Exp Cell Res; 2017 Dec; 361(2):246-256. PubMed ID: 29080795
[TBL] [Abstract][Full Text] [Related]
14. Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway.
Ai X; Mao F; Shen S; Shentu Y; Wang J; Lu S
BMC Cancer; 2018 Apr; 18(1):407. PubMed ID: 29642873
[TBL] [Abstract][Full Text] [Related]
15. Kaempferol promotes apoptosis in human bladder cancer cells by inducing the tumor suppressor, PTEN.
Xie F; Su M; Qiu W; Zhang M; Guo Z; Su B; Liu J; Li X; Zhou L
Int J Mol Sci; 2013 Oct; 14(11):21215-26. PubMed ID: 24284390
[TBL] [Abstract][Full Text] [Related]
16. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
Lin W; Xie J; Xu N; Huang L; Xu A; Li H; Li C; Gao Y; Watanabe M; Liu C; Huang P
Int J Biol Sci; 2018; 14(4):418-426. PubMed ID: 29725263
[TBL] [Abstract][Full Text] [Related]
17. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
To KKW; Wu WKK; Loong HHF
Eur J Pharmacol; 2018 Mar; 823():19-26. PubMed ID: 29378193
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA‑21 expression inhibits proliferation, and induces G1 arrest and apoptosis via the PTEN/AKT pathway in SKM‑1 cells.
Li G; Song Y; Li G; Ren J; Xie J; Zhang Y; Gao F; Mu J; Dai J
Mol Med Rep; 2018 Sep; 18(3):2771-2779. PubMed ID: 30015844
[TBL] [Abstract][Full Text] [Related]
20. PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells.
Cheng S; Qian K; Wang Y; Wang G; Liu X; Xiao Y; Wang X
J Cell Mol Med; 2019 May; 23(5):3724-3736. PubMed ID: 30912275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
